Brief: Granules India Announced Approval For The Store Brand OTC Equivalent Of Advil Dual Action Tablets
14/07/2023 04:10
July 14 (Reuters) - Granules India Ltd GRAN.NS :
* ANNOUNCED APPROVAL FOR THE STORE BRAND OTC EQUIVALENT OF
ADVIL
DUAL ACTION TABLETS
* US FDA APPROVED CO'S ABBREVIATED NEW DRUG APPLICATION FOR
ACETAMINOPHEN AND IBUPROFEN TABLETS
Source text for Eikon: ID:nBSE1Np9JB
Further company coverage: GRAN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake